Clinical Efficacy of Cefditoren Pivoxil for Exacerbation of Chronic Obstructive Pulmonary Disease

Trial Profile

Clinical Efficacy of Cefditoren Pivoxil for Exacerbation of Chronic Obstructive Pulmonary Disease

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Sep 2017

At a glance

  • Drugs Cefditoren pivoxil (Primary)
  • Indications Bacterial infections; Chronic obstructive pulmonary disease; Respiratory tract infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 May 2017 Status changed from recruiting to active, no longer recruiting.
    • 27 Feb 2015 Planned End Date changed from 31 Jul 2014 to 30 Apr 2017 as per University Hospital Medical Information Network - Japan record.
    • 28 Feb 2014 Planned number of patients changed from 50 to 40 as reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top